摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

喹喔啉-5,8-二酮 | 15250-38-1

中文名称
喹喔啉-5,8-二酮
中文别名
5,8-喹喔啉二酮
英文名称
quinoxaline-5,8-dione
英文别名
quinoxaline-5,8-quinone;5,8-quinoxalinedione;Chinoxalin-5,8-dion
喹喔啉-5,8-二酮化学式
CAS
15250-38-1
化学式
C8H4N2O2
mdl
——
分子量
160.132
InChiKey
GHLUWAJFYKILGZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    59.9
  • 氢给体数:
    0
  • 氢受体数:
    4

SDS

SDS:5abda6b496363958aab3eb7dc9901ea6
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    6,7-二氯喹喔啉-5,8-二酮 6,7-dichloroquinoxaline-5,8-dione 102072-82-2 C8H2Cl2N2O2 229.022

反应信息

  • 作为反应物:
    描述:
    喹喔啉-5,8-二酮 在 sodium azide 、 溶剂黄146 作用下, 以 四氢呋喃 为溶剂, 反应 2.0h, 以51%的产率得到6-Aminoquinoxaline-5,8-dione
    参考文献:
    名称:
    Synthesis and biological evaluation of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives
    摘要:
    A series of azanaphthoquinone pyrrolo-annelated derivatives attached to basic side chains have been synthesized. The antiproliferative activities of all compounds were evaluated on at least four different cell lines. The effects on cell cycle and intercalation were investigated. (c) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.05.003
  • 作为产物:
    参考文献:
    名称:
    Adachi, Nippon Kagaku Zasshi, 1955, vol. 76, p. 311,315
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Reaction of 2,5-dimethylpyrroles with quinones. Synthesis of new pyrrolylquinones
    作者:Dyes Claude Lion、Richard Baudry、Mir Hedayatullah、Louis Da Conceiçlato、Sylvie Genard、Jean Maignan
    DOI:10.1002/jhet.5570390118
    日期:2002.1
    The reaction of 1,4-naphthoquinone (1) with 2,5-dimethylpyrroles (7a-7d) gives only 3-(1,4-naphtho-quinonyl)-2,5-dimethylpyrroles. Extending the reaction to other quinones: 5-hydroxy-1,4-naphthoquinone (2), 1,2-naphthoquinone (3), quinoline-5,8-dione (4) and quinoxaline-5,8-dione (5), of which nothing was known, allows the synthesis of new pyrrolylquinones.
    1,4-萘醌(1)与2,5-二甲基吡咯(7a-7d)的反应仅产生3-(1,4-萘醌基)-2,5-二甲基吡咯。将反应扩展至其他醌:5-羟基-1,4-萘醌(2),1,2-萘醌(3),喹啉5,8-二酮(4)和喹喔啉-5,8-二酮(5) ,其中什么都不知道,可以合成新的吡咯基醌。
  • Synthesis of Medicinally Interesting 2,4-Diamino-9<i>H</i>-pyrimido[4,5-<i>b</i>]indol-6-ols via Extension of the Nenitzescu Reaction
    作者:Reinhard Troschütz、Bernd Dotzauer
    DOI:10.1055/s-2004-822887
    日期:——
    The title compounds 6 were prepared by a one-step procedure from 1,4-benzoquinone (1) and pyrimidine-2,4,6-triamines 2 via an extension of the Nenitzescu reaction. Formation of 9H-pyrimido[4,5-b]indoles 6 can be calculated by 1 3 C NMR values of C-5 of the pyrimidine-2,4,6-triamines 2.
    标题化合物 6 通过一步法从 1,4-苯醌 (1) 和嘧啶-2,4,6-三胺 2 经由 Nenitzescu 反应的延伸制备。9H-嘧啶并[4,5-b]吲哚6的形成可以通过嘧啶-2,4,6-三胺2的C-5的1 3 C NMR值计算。
  • Computational design, synthesis and biological evaluation of para-quinone-based inhibitors for redox regulation of the dual-specificity phosphatase Cdc25B
    作者:Shahar Keinan、William D. Paquette、John J. Skoko、David N. Beratan、Weitao Yang、Sunita Shinde、Paul A. Johnston、John S. Lazo、Peter Wipf
    DOI:10.1039/b806712k
    日期:——
    Quinoid inhibitors of Cdc25B were designed based on the Linear Combination of Atomic Potentials (LCAP) methodology. In contrast to a published hypothesis, the biological activities and hydrogen peroxide generation in reducing media of three synthetic models did not correlate with the quinone half-wave potential, E1/2.
    根据原子电位线性组合(LCAP)方法设计了 Cdc25B 的醌类抑制剂。与已发表的假设相反,三种合成模型的生物活性和在还原介质中生成的过氧化氢与醌半波电位 E1/2 并不相关。
  • 정공 주입 특성을 구비한 유기 화합물 및 그를 이용한 유기 발광 소자와 디스플레이 장치
    申请人:LG Display Co.,Ltd. 엘지디스플레이 주식회사(119981018655) Corp. No ▼ 110111-0393134
    公开号:KR20150030132A
    公开(公告)日:2015-03-19
    본 발명은, 하기 화학식 1: 화학식 1 로 표시되는 정공 주입 특성을 구비한 유기 화합물 및 그를 이용한 유기 발광 소자와 디스플레이 장치에 관한 것으로서, 본 발명에 따르면 유기 발광 소자의 구동 전압을 낮출 수 있다.
    本发明涉及具有具有以下化学式1:化学式1的正孔注入特性的有机化合物,以及基于该化合物的有机发光器件和显示器件,根据本发明,可以降低有机发光器件的驱动电压。
  • Quinoxalinedione leukotriene release inhibitors
    申请人:Eli Lilly and Company
    公开号:US04486432A1
    公开(公告)日:1984-12-04
    This invention provides for novel quinoxalinedione derivatives, the use of quinoxalinedione derivatives in treating animals suffering from immediate hypersensitivity reactions and conditions characterized by excessive release of leukotrienes, and formulations of the quinoxalinedione derivatives.
    该发明提供了新型喹诺酮二酮衍生物,喹诺酮二酮衍生物在治疗患有即时超敏反应和伴有白三烯过度释放的动物疾病的用途,以及喹诺酮二酮衍生物的配方。
查看更多